Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
44%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
25%
ALSO IN PPH
PPH
27
HOLDINGS
54%
ALSO IN IHE
SECTOR DRIFT (IHE minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 21.5% | 20.0% | 20.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 4.8% | 4.6% |
|
MERCK & CO. INC. | 4.5% | 9.9% | 4.5% |
|
JOHNSON & JOHNSON | 22.6% | 4.5% | 4.5% |
|
PFIZER INC | 3.9% | 4.5% | 3.9% |
IHE Overweight Relative to PPH
|
JOHNSON & JOHNSON | 18.1% |
|
ROYALTY PHARMA PLC CLASS A | 4.4% |
|
VIATRIS, INC. | 3.3% |
 |
JAZZ PHARMACEUTICALS PLC | 2.4% |
|
ELANCO ANIMAL HEALTH, INC. | 2.4% |
|
CRINETICS PHARMACEUTICALS INC | 2.0% |
|
ZOETIS INC | 1.6% |
|
ELI LILLY & CO | 1.6% |
|
AXSOME THERAPEUTICS, INC. | 1.6% |
|
CORCEPT THERAPEUTICS INC | 1.5% |
IHE Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.4% |
|
MERCK & CO. INC. | -5.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.4% |
|
ABBVIE INC | -4.7% |
|
MCKESSON CORP | -4.5% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
ASTRAZENECA PLC-SPONS ADR | -3.8% |
|
CENCORA INC | -3.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -3.1% |